Chao Tu

A novel and effective approach to generate germline-like monoclonal antibodies by integration of phage and mammalian cell display platforms

T. Ying, Wei Zhang, Xiaolong Tian, 2021, Acta pharmacologica Sinica.

Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody

Zhenguo Chen, Lu Lu, T. Ying, 2021, Cell.

A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors

T. Ying, Yanling Wu, Chunyu Wang, 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

Identification of Human Single-Domain Antibodies against SARS-CoV-2

Lu Lu, T. Ying, S. Xia, 2020 .

Fully human single-domain antibodies against SARS-CoV-2

Lu Lu, Shibo Jiang, T. Ying, 2020, bioRxiv.

Identification of Human Single-Domain Antibodies against SARS-CoV-2

Lu Lu, Shibo Jiang, T. Ying, 2020, Cell Host & Microbe.

Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus Infection

D. Dimitrov, P. Prabakaran, I. Sidorov, 2019, Journal of Virology.

Defining a highly conserved cryptic epitope for antibody recognition of SARS-CoV-2 variants

T. Ying, Yanling Wu, Pengfei Wang, 2023, Signal transduction and targeted therapy.